Skip to search.
 TSX Down 0.60% TSX Ventures Down 1.08%

More On TTH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc (TTH.TO)

-Toronto
2.69 Down 0.06(2.18%) 2:18PM EDT
Add to Portfolio
Prev Close:2.75
Open:2.70
Bid:2.62
Ask:2.73
1y Target Est:N/A
Beta:0.66
Next Earnings Date:N/A
Day's Range:2.61 - 2.75
52wk Range:2.50 - 11.50
Volume:5,595
Avg Vol (3m):9,017
Market Cap:104.53M
P/E (ttm):N/A
EPS (ttm):-1.45
Div & Yield:0.06 (0.20%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:29-Dec-10

Analysts

Annual EPS Est (Jun-15) :-1.22
Quarterly EPS Est (Jun-15) :N/A
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback